相关实验视频

Updated: Jul 10, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

基因重定位E3酶以增强CAR T细胞治疗

Isabel C Lane¹, Gabriele Kembuan¹, Jeannie Carreiro²

¹Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Cell chemical biology

|November 21, 2023

概括

新的降解蛋白质通过克服瘤抑制来增强仿真抗原受体 (CAR) T 细胞疗法. 这种合成生物学方法改善了CAR T细胞功能和癌症治疗的抗瘤功效.

科学领域:

生物技术是生物技术.
免疫治疗是一种免疫疗法.
合成生物学合成生物学

背景情况:

化学抗原受体 (CAR) T细胞疗法代表了癌症治疗的重大进展.
卡尔T细胞功能障碍和抑制信号限制了它们的抗瘤疗效.
克服这些局限性对于改善治疗结果至关重要.

研究的目的:

开发新的双功能融合降解蛋白来增强CAR T细胞疗法.
设计条件和多特异性蛋白质降解策略.
研究这些降解剂在克服TGFβ介导抑制方面的潜力.

主要方法:

设计的双功能融合"降解"蛋白质,将目标蛋白与E3结合酶复合体结合起来.
使用可诱导转基因表达或小分子依赖E3招募的条件降解.
设计了针对SMAD2和SMAD3的SMAD降解器,以阻止TGFβ信号传输.

主要成果:

降解SMAD的CAR T细胞对TGFβ诱导的抑制的敏感性降低.
改造的CAR T细胞在体内表现出增强的抗瘤功效.
验证了一种临床上适合的合成生物学平台,用于内源性蛋白质降解.

结论:

开发的降解蛋白平台为重新编程E3酶特异性提供了一种多功能工具.
条件和多特异性蛋白质降解可以增强CAR T细胞疗法的效力.
这种方法对改善癌症治疗策略具有重大前景.

关键词:

在CAR T细胞中.癌症免疫疗法免疫疗法细胞免疫疗法细胞免疫疗法合成生物学合成生物学有针对性的蛋白质降解降解.在任何地方都是无处不在的.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...